CN1166388C - Medicine for treating nosal inflammation - Google Patents

Medicine for treating nosal inflammation Download PDF

Info

Publication number
CN1166388C
CN1166388C CNB021002991A CN02100299A CN1166388C CN 1166388 C CN1166388 C CN 1166388C CN B021002991 A CNB021002991 A CN B021002991A CN 02100299 A CN02100299 A CN 02100299A CN 1166388 C CN1166388 C CN 1166388C
Authority
CN
China
Prior art keywords
herba
radix
chlorphenamine
medicine
flos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021002991A
Other languages
Chinese (zh)
Other versions
CN1404854A (en
Inventor
陈炳南
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021002991A priority Critical patent/CN1166388C/en
Publication of CN1404854A publication Critical patent/CN1404854A/en
Application granted granted Critical
Publication of CN1166388C publication Critical patent/CN1166388C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a medicine preparation which is prepared by natural Chinese medicines and is used for treating acute rhinitis, chronic rhinitis and nasosinusitis. The medicine preparation is formed by preparing fifteen Chinese medicines comprising magnolia flower, xanthium, honeysuckle flower, centipeda herb, calamus, herba agastachis, perilla leaf, mint, radix gentianae, bupleurum root, chuanxiong rhizome, dahurian angelica root, platycodon root, houttuynia and scutellaria root and a western medicine of chlorphenamine maleate as raw materials.

Description

A kind of medicine for the treatment of nosal inflammation
The present invention relates to be used for the treatment of the medicine of acute and chronic rhinitis, sinusitis, particularly is the pharmaceutical preparation of main preparation with the Chinese crude drug.
Rhinitis, sinusitis are frequently-occurring disease, the commonly encountered diseases among the crowd.To show as the course of disease long more, and easily recurrence brings a lot of inconvenience for patient's living and studying.At present the treatment of rhinitis, sinusitis is not still had special-purpose specific medicament, use general anti-inflammation drugs and symptomatic treatment more.The treatment acute and chronic rhinitis of selling on the market, the medicine of sinusitis can't be satisfactory at aspects such as effective percentage, persistency, relapse rates.Its deficiency is, or can not be effective to everyone, or relapse rate is higher after stopping using medicine.Therefore be necessary to excavate more effective, easy to use, cheap treatment acute and chronic rhinitis, the medicine of sinusitis.And its unique advantage and value is arranged according to the medicine of the theoretical development of Chinese medicine and pharmacy.
The object of the present invention is to provide a kind of serves as the pharmaceutical preparation of main preparation with the Chinese medicine natural drug, and it can reach treating both the principal and secondary aspects of a disease aspect treatment acute and chronic rhinitis, sinusitis, better curative effect is arranged.
The present invention seeks to realize by the following method.
Crude drug of the present invention is equipped with a small amount of Western medicine chlorphenamine (Chlorpheniraminum) based on 15 kinds of Chinese medicine natural drugs.15 kinds of Chinese medicines are Flos Magnoliae flower, Fructus Xanthii, Flos Lonicerae, Herba Centipedae, Rhizoma Acori Graminei, Herba Pogostemonis, Folium Perillae, Herba Menthae, Radix Gentianae, Radix Bupleuri, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Radix Platycodonis, Herba Houttuyniae, Radix Scutellariae.They are equipped with the pharmacy acceptable carrier, adopt common process, manufacture capsule, oral liquid or other dosage forms that is suitable for.
Pharmaceutical compositions consumption proportion scope of the present invention is:
Flos Magnoliae is spent 10~14% Fructus Xanthii, 8~12% Flos Loniceraes, 6~11% Herba Centipedae 6~11%
Rhizoma Acori Graminei 3~7% Herba Pogostemoniss 4~9% Folium Perillaes 3~8% Herba Menthaes 3~7%
Radix Gentianae 4~9% Radix Bupleuri 4~9% Rhizoma Chuanxiongs 4~9% Radixs Angelicae Dahuricae 3~7%
Radix Platycodonis 3~7% Herba Houttuyniae 6~11% Radix Scutellariaes 3~7% chlorphenamines 0.1~0.4%
Pharmaceutical compositions consumption optimum ratio of the present invention is:
Flos Magnoliae is spent 11~12% Fructus Xanthii, 9~11% Flos Loniceraes, 7~9% Herba Centipedae 7~9%
Rhizoma Acori Graminei 4~6% Herba Pogostemoniss 5~7% Folium Perillaes 4~6% Herba Menthaes 4~6%
Radix Gentianae 5~7% Radix Bupleuri 5~7% Rhizoma Chuanxiongs 5~7% Radixs Angelicae Dahuricae 4~6%
Radix Platycodonis 4~6% Herba Houttuyniae 7~9% Radix Scutellariaes 4~6% chlorphenamines 0.1~0.2%
The best proportioning of ingredient consumption of the present invention is:
Flos Magnoliae is spent 12% Fructus Xanthii, 10% Flos Lonicerae, 8% Herba Centipedae, 8% Rhizoma Acori Graminei 5%
Herba Pogostemonis 6% Folium Perillae 5% Herba Menthae 5% Radix Gentianae 6% Radix Bupleuri 6%
Rhizoma Chuanxiong 6% Radix Angelicae Dahuricae 5% Radix Platycodonis 5% Herba Houttuyniae 7.8% Radix Scutellariae 5%
Chlorphenamine 0.2%
Formulation method:
The Chinese medicine preprocessing need only be pulverized Fructus Xanthii.
1. glue wafer.Except that chlorphenamine and Herba Menthae, with all the other 14 kinds of Chinese medicine mixing watered boilings 3 times, decocted 1~3 hour at every turn, cross the leaching decoction liquor; The leaching decoction liquor was crossed in the Herba Menthae watered boiling in 20~40 minutes; Merge each time decoction liquor, reheat is condensed into paste, dries then or dries, and row is pulverized again, drops into chlorphenamine, and mix homogeneously incapsulates, and is finished product.
2. system oral liquid.Except that chlorphenamine and Herba Menthae, with all the other 14 kinds of Chinese medicine mixing watered boilings 3 times, decocted 1~3 hour at every turn, cross the leaching decoction liquor; The leaching decoction liquor was crossed in the Herba Menthae watered boiling in 20~40 minutes; Merge each time decoction liquor, add chlorphenamine and antiseptic, packing is standby.
3. also can make dosage forms such as tablet, honeyed pill, the watered pill, granular pattern electuary by usual way.
More than various dosage forms adult consumptions every day be equivalent to crude drug 120~160 grams, divide and take for 2~3 times.
Motherland's medical science thinks, rhinitis, sinusitis are many because of the evil poison of diseases caused by exogenous pathogenic factor, wind and heat in the lung meridian, and the gallbladder internal organs is hot and suffocating, the damp-heat in the spleen and stomach circulation criminal's of going up intrusion nasal sinuses and sending out.Clinical manifestation is nasal obstruction, the nasal mucus of suppurating, headache and general malaise.In the prescription of the present invention Flos Magnoliae flower, Fructus Xanthii, Herba Centipedae dispel the wind, the sharp key of pain relieving, stuffy nose relieving; Flos Lonicerae, Herba Houttuyniae, Herba Pogostemonis, the bath of Radix Angelicae Dahuricae dispelling wind are wet, heat-clearing and toxic substances removing, detumescence and apocenosis; Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping; Radix Platycodonis ascending lung qi, priming are up.All medicines share, and play altogether that the bath of dispeling the wind is wet, the effect of heat-clearing and toxic substances removing, reducing swelling and alleviating pain, the sharp key of stuffy nose relieving.Add an amount of chlorphenamine again,, reach treating both the principal and secondary aspects of a disease, the purpose that As the medicine took effect, the symptoms lessened with the effect of the antiallergic action of strengthening pure Chinese medicine.
The inventor uses the various acute and chronic rhinitis of Drug therapy of the present invention, allergic rhinitis, the tens of examples of sinusitis.Wherein 18 complete examples of collection of data are carried out statistical analysis, satisfactory effect.Male's 12 examples wherein, women's 6 examples; The oldest 42 years old, minimum 8 years old.The course of disease is the longest 3 months, and is the shortest 12 days.Clinical manifestation such as all cases all have in various degree nasal obstruction, watery nasal discharge, nasal mucosa redness, hyposmia, feel dizzy.Fully recover after 8~16 days through taking medicine of the present invention.The tracing study several months, rare recurrence.
The invention will be further described by the following examples.
Embodiment 1 produces capsule
Flos Magnoliae is spent 240 gram Fructus Xanthii, 200 gram Flos Loniceraes, 160 gram Herba Centipedae, 160 gram Rhizoma Acori Gramineis, 100 grams
Herba Pogostemonis 120 gram Folium Perillaes 100 gram Herba Menthaes 100 cron Radix Gentianae 120 gram Radix Bupleuri 120 grams
The Rhizoma Chuanxiong 120 gram Radixs Angelicae Dahuricae 100 gram Radix Platycodoniss 100 gram Herba Houttuyniae 160 gram Radix Scutellariaes 100 grams
Chlorphenamine 4 grams
Above crude drug is pulverized Fructus Xanthii except that chlorphenamine and Herba Menthae in advance, with all the other 13 kinds of Chinese medicine mixing watered boilings 3 times, decocts 1~3 hour at every turn, crosses the leaching decoction liquor; The leaching decoction liquor was crossed in the Herba Menthae watered boiling in 30 minutes; Merge each time decoction liquor, reheat is condensed into paste, oven dry then, and row is pulverized again, drops into chlorphenamine, and mix homogeneously incapsulates, and is finished product.
The total consumption of present embodiment crude drug is 2004 grams, is equivalent to crude drug 120~160 grams by adult's consumption every day and calculates, and is equivalent to the consumption in 2 weeks of adult patient (14 days) approximately.
Embodiment 2 produces oral liquid
Flos Magnoliae is spent 220 gram Fructus Xanthii, 220 gram Flos Loniceraes, 140 gram Herba Centipedae, 180 gram Rhizoma Acori Gramineis, 80 grams
Herba Pogostemonis 140 gram Folium Perillaes 90 gram Herba Menthaes 120 cron Radix Gentianae 100 gram Radix Bupleuri 140 grams
The Rhizoma Chuanxiong 100 gram Radixs Angelicae Dahuricae 120 gram Radix Platycodoniss 80 gram Herba Houttuyniae 180 gram Radix Scutellariaes 100 grams
Chlorphenamine 3 grams
Above crude drug is pulverized Fructus Xanthii except that chlorphenamine and Herba Menthae in advance, and with all the other 13 kinds of Chinese medicine mixing watered boilings 3 times, each time decocting time was respectively 3 hours, 2 hours, 1 hour.Cross the leaching decoction liquor; The leaching decoction liquor was crossed in the Herba Menthae watered boiling in 30 minutes; Merge each time decoction liquor, add chlorphenamine and antiseptic, mix homogeneously, packing is finished product.
The total consumption of present embodiment crude drug is 2013 grams, is equivalent to crude drug 120~160 grams by adult's consumption every day and calculates, and is equivalent to the consumption in 2 weeks of adult patient (14 days) approximately.
Embodiment 3 produces capsule
Flos Magnoliae is spent 260 gram Fructus Xanthii, 160 gram Flos Loniceraes, 220 gram Herba Centipedae, 120 gram Rhizoma Acori Gramineis, 100 grams
Herba Pogostemonis 120 gram Folium Perillaes 100 gram Herba Menthaes 140 cron Radix Gentianae 90 gram Radix Bupleuri 160 grams
The Rhizoma Chuanxiong 140 gram Radixs Angelicae Dahuricae 100 gram Radix Platycodoniss 90 gram Herba Houttuyniae 160 gram Radix Scutellariaes 100 grams
Chlorphenamine 2.5 grams
Above crude drug is pulverized Fructus Xanthii except that chlorphenamine and Herba Menthae in advance, and with all the other 13 kinds of Chinese medicine mixing watered boilings 3 times, each time decocting time was respectively 3 hours, 2.5 hours, 2 hours.Cross the leaching decoction liquor; The leaching decoction liquor was crossed in the Herba Menthae watered boiling in 20 minutes; Merge each time decoction liquor, reheat is condensed into paste, dries then, and row is pulverized again, drops into chlorphenamine, and mix homogeneously incapsulates, and is finished product.
The total consumption of present embodiment crude drug is 2062.5 grams, is equivalent to crude drug 120~160 grams by adult's consumption every day and calculates, and is equivalent to the consumption in 2 weeks of adult patient (14 days) approximately.

Claims (6)

1. a medicine for the treatment of acute and chronic rhinitis, sinusitis is characterized in that, it is made by following materials of weight proportions medicine:
Flos Magnoliae is spent 10~14% Fructus Xanthii, 8~12% Flos Loniceraes, 6~11% Herba Centipedae, 6~11% Rhizoma Acori Gramineis 3~7%
Herba Pogostemonis 4~9% Folium Perillaes 3~8% Herba Menthaes 3~7% Radix Gentianaes 4~9% Radix Bupleuri 4~9%
Rhizoma Chuanxiong 4~9% Radixs Angelicae Dahuricae 3~7% Radix Platycodoniss 3~7% Herba Houttuyniae 6-11% Radix Scutellariaes 3~7%
Chlorphenamine 0.1~0.4%.
2. medicine according to claim 1 is characterized in that, the consumption proportion of each crude drug is,
Flos Magnoliae is spent 11~12% Fructus Xanthii, 9~11% Flos Loniceraes, 7~9% Herba Centipedae, 7~9% Rhizoma Acori Gramineis 4~6%
Herba Pogostemonis 5~7% Folium Perillaes 4~6% Herba Menthaes 4~6% Radix Gentianaes 5~7% Radix Bupleuri 5~7%
Rhizoma Chuanxiong 5~7% root of Dahurian angelicas 4~6% Radix Platycodoniss 4~6% Herba Houttuyniae 7~9% Radix Scutellariaes 4~6%
Chlorphenamine 0.1~0.2%.
3. medicine according to claim 1 is characterized in that, the consumption proportion of each crude drug is,
Flos Magnoliae is spent 12% Fructus Xanthii, 10% Flos Lonicerae, 8% Herba Centipedae, 8% Rhizoma Acori Graminei, 5% Herba Pogostemonis 6%
Folium Perillae 5% Herba Menthae 5% Radix Gentianae 6% Radix Bupleuri 6% Rhizoma Chuanxiong 6% Radix Angelicae Dahuricae 5%
Radix Platycodonis 5% Herba Houttuyniae 7.8% Radix Scutellariae 5% chlorphenamine 0.2%.
4. according to claim 1 or 2 or 3 described medicines, it is characterized in that said medicament is capsule or oral liquid.
5. the preparation method of medicine according to claim 4, it is characterized in that, 14 kinds of decocting for Chinese herbal medicine except that chlorphenamine and Herba Menthae 3 times, Herba Menthae decocted 20~40 minutes, crossed the leaching decoction liquor and merged, reheat is condensed into cream, dry then or dry, row is pulverized again, drops into chlorphenamine, mix homogeneously incapsulates.
6. the preparation method of pharmaceutical preparation according to claim 4 is characterized in that, 14 kinds of decocting for Chinese herbal medicine except that chlorphenamine and Herba Menthae 3 times, and Herba Menthae decocted 20~40 minutes, crossed the leaching decoction liquor and merged, and added chlorphenamine and antiseptic, was distributed into oral liquid.
CNB021002991A 2002-01-18 2002-01-18 Medicine for treating nosal inflammation Expired - Fee Related CN1166388C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021002991A CN1166388C (en) 2002-01-18 2002-01-18 Medicine for treating nosal inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021002991A CN1166388C (en) 2002-01-18 2002-01-18 Medicine for treating nosal inflammation

Publications (2)

Publication Number Publication Date
CN1404854A CN1404854A (en) 2003-03-26
CN1166388C true CN1166388C (en) 2004-09-15

Family

ID=4739292

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021002991A Expired - Fee Related CN1166388C (en) 2002-01-18 2002-01-18 Medicine for treating nosal inflammation

Country Status (1)

Country Link
CN (1) CN1166388C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101332279B (en) * 2008-07-15 2010-09-08 何社明 Traditional Chinese medicine preparation for treating nasal sinusitis, rhinopolypus and nasopharyngitis
CN102018838A (en) * 2010-11-15 2011-04-20 张英堂 Medicine for treating chronic rhinitis

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100393338C (en) * 2006-02-24 2008-06-11 徐利洪 Rhinitis ointment and preparation method thereof
CN100425224C (en) * 2006-12-04 2008-10-15 刘粉叶 Chinese medicinal nasal wash and preparation method thereof
CN101181408B (en) * 2007-11-30 2010-10-06 李福强 Chinese medicine composition for the oral medication of chronic sinusitis
CN101342277B (en) * 2008-08-19 2011-04-06 冯苏涛 Externally used antimicrobial spray for treating snore and preparation method thereof
CN102743731B (en) * 2012-07-14 2013-10-16 济南伟传信息技术有限公司 Chinese medicament for treating chronic rhinitis
CN103830564B (en) * 2014-03-10 2017-01-04 宁波大学 For treating the endo-medicine of chronic sinusitis
CN104398964A (en) * 2014-12-01 2015-03-11 郭文喜 Traditional Chinese medicinal composition for treating allergic rhinitis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101332279B (en) * 2008-07-15 2010-09-08 何社明 Traditional Chinese medicine preparation for treating nasal sinusitis, rhinopolypus and nasopharyngitis
CN102018838A (en) * 2010-11-15 2011-04-20 张英堂 Medicine for treating chronic rhinitis

Also Published As

Publication number Publication date
CN1404854A (en) 2003-03-26

Similar Documents

Publication Publication Date Title
CN1315525C (en) Chinese traditional medicine for treating breast disease and preparing technique
CN101129636A (en) Medicine for treating nasal inflammation
CN1166388C (en) Medicine for treating nosal inflammation
CN1168456C (en) Capsule for treating nasosinusitis
CN100335097C (en) Medicament for treating rhinitis
CN1600356A (en) Combination of Chinese traditional medicine for curing chronic pharyngitis and preparation method
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN1071123C (en) Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites
CN111407808B (en) Traditional Chinese medicine composition and preparation method and pharmaceutical application thereof
CN1335174A (en) Stomatopathy and throat disease treating health care medicine and its production process
CN1443545A (en) Medicine for curing acne and its preparation method
CN101502597B (en) Medicament for treating stomachache and preparation method thereof
CN101637536B (en) Medicine for treating chronic sinusitis and preparation method thereof
CN101732469B (en) Application of Chinese medicinal composition in preparation of medicament for treating aphonia
CN1261130C (en) Medicine for dispelling tinea
CN101028451A (en) Chinese medicine for treating tic douloureux
CN101143199A (en) Traditional Chinese medicine for treating chronic bronchitis
CN110237119A (en) A kind of pharmaceutical composition that treating mucous membrane of mouth class disease and preparation method and purposes
CN1899574A (en) Chinese medicine composition for preventing and controlling liver cancer and its use
CN1274360C (en) Antiphlogistic and antitussive medicine powder
CN112168931B (en) A pharmaceutical composition for treating oral ulcer, and its preparation method
CN1265908A (en) Cough-relieving medicine
CN101129554A (en) Traditional Chinese medicine for treating migraine
CN1907389A (en) Pharmaceutical composition for treating vocal cords disease and its preparation and application
CN1891281A (en) Chinese medicine preparation for treating wind-cold disease, and its preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee